0001213900-24-015030.txt : 20240216
0001213900-24-015030.hdr.sgml : 20240216
20240216193938
ACCESSION NUMBER: 0001213900-24-015030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Geffken Daniel E.
CENTRAL INDEX KEY: 0001314756
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40877
FILM NUMBER: 24650193
MAIL ADDRESS:
STREET 1: DAMONMILL SQUARE
STREET 2: SUITE 6A
CITY: CONCORD
STATE: MA
ZIP: 01742
FORMER NAME:
FORMER CONFORMED NAME: GEFFKEN DANIEL E
DATE OF NAME CHANGE: 20050119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CERO THERAPEUTICS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001870404
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 871088814
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 HASKINS WAY
STREET 2: SUITE 230
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-407-2376
MAIL ADDRESS:
STREET 1: 201 HASKINS WAY
STREET 2: SUITE 230
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: PHOENIX BIOTECH ACQUISITION CORP.
DATE OF NAME CHANGE: 20210630
4
1
ownership.xml
X0508
4
2024-02-14
1
0001870404
CERO THERAPEUTICS HOLDINGS, INC.
CERO
0001314756
Geffken Daniel E.
2201 BROADWAY, SUITE 705
OAKLAND
CA
94612
0
1
0
0
Chief Financial Officer
0
Class A Common Stock
2024-02-14
4
J
0
10002
A
10002
D
Represents shares of Class A Common Stock distributed in-kind by Phoenix Biotech Sponsor, LLC (the "Sponsor") to its members, pro rata and without consideration.
/s/ Chris Ehrlich, Attorney-in-Fact
2024-02-16